MEDP Stock Signals: 67 Detections Since 2018
JumpstartSignal's 5-stage screening system flagged Medpace Holdings (MEDP) on 67 individual trading days (8 signal clusters) across our 14-year backtest (2012–2025). Best signal: +1449% from Apr 17, 2018 vs +186% SPY over the same period.
(vs +186% SPY)
8/8 clusters
8 clusters
per signal
About Medpace Holdings
Medpace Holdings is a full-service contract research organisation (CRO) specialising in Phase I–IV clinical development for biotech and pharmaceutical companies. Unlike larger generalist CROs, Medpace focuses on small and mid-sized biotech clients who value its therapeutic expertise and hands-on engagement, driving consistently high utilisation rates and strong organic revenue growth.
MEDP Signal History (2018–2019)
Each row represents one signal cluster — when consecutive daily signals appeared they are grouped together. Entry price shown is the best entry within each cluster. Returns measured to 2026-02-01.
| Signal Date | Entry Price | Return | Price (Feb '26) | SPY (same period) | Alpha |
|---|---|---|---|---|---|
| Feb 16, 2018 2-day | $38.02 | +1432% | $582.47 | +185% | +1247% |
| Apr 17, 2018 2-day | $37.60 | +1449% | $582.46 | +186% | +1263% |
| Aug 7, 2018 27-day | $55.32 | +953% | $582.46 | +168% | +785% |
| Dec 4, 2018 2-day | $61.40 | +849% | $582.50 | +184% | +665% |
| Jan 17, 2019 6-day | $60.13 | +869% | $582.48 | +189% | +679% |
| Feb 14, 2019 | $68.36 | +752% | $582.50 | +178% | +574% |
| Aug 23, 2019 25-day | $78.91 | +638% | $582.51 | +165% | +473% |
| Dec 17, 2019 2-day | $80.34 | +625% | $582.47 | +135% | +490% |
MEDP Return vs SPY — per signal cluster
Past performance does not indicate future results. Returns calculated from each signal's entry date to 2026-02-01. Consecutive daily signals within 14 days are grouped as one cluster; best entry price within the cluster is shown. Data sourced from JumpstartSignal's 14-year backtest using historical prices.
How JumpstartSignal Screened MEDP
Each MEDP signal above passed through all five stages:
Stage 3 scores quality signals — ROE, low debt, MA stack (0–60 pts) — and entry timing signals — golden cross, breakout volume, VWAP momentum (0–20 pts). Stage 4 adds AI news sentiment (0–10 pts) and a sector bonus (0–10 pts) for a combined score out of 100. MEDP reached ✅ OPPORTUNITY status (score ≥70) — appearing in the daily watchlist alongside 🏆 SPOTLIGHT (≥73) signals.
Full methodology →Get signals like these delivered daily
When stocks pass all 5 stages of our screening system, the signal lands in your inbox each trading day.
No spam. Unsubscribe in one click.